Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)

Background
The Gabriella Miller Kids First Pediatric Research Program, initiated by the NIH, aims to advance the understanding of childhood cancers and congenital anomalies through genetic research. The program encourages the submission of pediatric cohort samples for whole genome sequencing to uncover genetic contributions to these conditions and enhance the Kids First Data Resource.

Grant Details
The grant involves proposing sequencing of existing cohorts related to pediatric cancer or congenital anomalies. Tasks include: conducting whole genome, exome, and transcriptome sequencing; performing long-read sequencing, proteomics, and epigenomic assays on tumor or affected tissue when justified; and sharing resultant data along with clinical and phenotypic data with the research community through the Kids First Data Resource Center.

Eligibility Requirements
Eligibility is open to applicants proposing relevant research that aligns with the goals of elucidating genetic contributions to childhood cancers and congenital anomalies. Specific preferences may be given to those who can demonstrate a strong connection to existing pediatric cohorts.

Period of Performance
The contract will be performed over a period that spans multiple years.

Grant Value
The total value of the grant is not explicitly stated in the document; however, it is implied that individual grant awards will vary based on the proposed research scope and requirements.